Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 80
  • Start Date: December 17, 2020
Determining Biomarkers of Trained Immunity in a Randomized Controlled Trial of the Measles, Mumps, and Rubella Vaccine - a Sub-study of the CROWN CORONATION Trial
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Biological
  • Participants: 12000
  • Start Date: October 12, 2020
Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 60
  • Start Date: August 17, 2020
Use of a Live Attenuated Vaccine Repurposed as an Innate Immune-based Preventive Against COVID-19-associated Sepsis/Inflammation
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 840
  • Start Date: May 22, 2020
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 920
  • Start Date: May 2020
Randomized, Double-blind, Controlled Phase Ⅳ Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine in Healthy Infants Aged 8 ~12 Months.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Biological
  • Participants: 45
  • Start Date: February 2020
The Efficacy of Intralesional Measles, Mumps, Rubella (MMR) Vaccine, Intralesional Candidal Antigen and Topical Podophyllin in Treatment of Genital Warts: A Comparative Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 372
  • Start Date: July 26, 2019
A Randomized, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Measles, Mumps, and Rubella Combined Live Attenuated Vaccine/ Encephalitis Live Attenuated Vaccine
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 1540
  • Start Date: December 14, 2018
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 525
  • Start Date: October 17, 2018
Safety and Immunogenicity of a 3-Dose Schedule of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 940
  • Start Date: October 4, 2018
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 3080
  • Start Date: September 17, 2018
A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 2475
  • Start Date: April 25, 2018
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Showing 1-12 of 14